Automation index

How much of a Hepatologist’s job can AI already do?

A fibroscan comes earlier. Biopsying the liver and calling the transplant do not.

This percentage does not predict how many people will lose their jobs.

Task comparison

IS WORK OVER?

27%

AI can already do 27% of this job.

#158 / 643

Hepatologist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Labs, fibroscan and the stage. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Clinic, the drink and the one who denies it. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Biopsy, the risk and not needling extra. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Antiviral, adherence and the one who quits. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The transplant board and not jumping to a yes. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Call the liver, and talking to the family. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low

IS WORK OVER?

27%

#153 / 643

Hospital pharmacist

Task weights are our estimates based on O*NET frequency data, not time shares published by O*NET.

The time saving for each task is estimated separately.

Task	Share	AI	Points
Transcription, reconciliation and the error. Estimate No public source provides a precise figure. This is our estimate.	18%	48%	+8.6
Validate, the interaction and the one that cannot. Estimate No public source provides a precise figure. This is our estimate.	16%	40%	+6.4
Chemo, the cabinet and not mixing the batch. Estimate No public source provides a precise figure. This is our estimate.	16%	22%	+3.5
Ward, the doubt and going down to see the patient. Estimate No public source provides a precise figure. This is our estimate.	16%	28%	+4.5
The board, the expensive drug and not yielding to pressure. Estimate No public source provides a precise figure. This is our estimate.	18%	14%	+2.5
Validate the regimen, and not missing the error. Estimate No public source provides a precise figure. This is our estimate.	16%	12%	+1.9
Total	100%		27%

Modelled workweek: 100% · Public evidence: 0% · Estimate: 100% · Confidence: Low